MA Johnson

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Clinical NMR imaging of the brain in children: normal and neurologic disease

MA Johnson, Pennock Jm, G. M. Bydder et al. · American Journal of Roentgenology · 1983 · 147 citations

Medicine, Pediatrics, Radiology +17

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011

A L Pozniak, KM Coyne, A.R. Freedman et al. · HIV Medicine · 2011 · 129 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo et al. · The Lancet HIV · 2017 · 96 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Immune reconstitution pneumonitis following <i>Pneumocystis carinii</i> pneumonia in HIV‐infected subjects

SM Barry, AR Deery, MA Johnson et al. · HIV Medicine · 2002 · 79 citations

Veterinary Medicine, Immunology, Infectious Diseases +17